Haleos Labs (BOM:540679) Long-Term Debt: ₹500 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540679 Haleos Labs Ltd BOM:540679
70 GF Score
Price ₹1,439.10
GF Value ₹1,130.80
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Haleos Labs Long-Term Debt?

Haleos Labs BOM:540679 +1.22% 70 Long-Term Debt is ₹500 Mil as of Mar. 2026. GuruFocus rates BOM:540679 with a GF Score™ of 70/100 and a GF Value™ of ₹1,130.80 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Haleos Labs's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹500 Mil.

Haleos Labs's quarterly Long-Term Debt declined from Sep. 2025 (₹127 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹500 Mil).

Haleos Labs's annual Long-Term Debt declined from Mar. 2024 (₹331 Mil) to Mar. 2025 (₹183 Mil) but then increased from Mar. 2025 (₹183 Mil) to Mar. 2026 (₹500 Mil).

Haleos Labs  (BOM:540679) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Haleos Labs Long-Term Debt Related Terms

Haleos Labs Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Haleos Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleos Labs Long-Term Debt Chart

Haleos Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 403.32 549.42 331.45 182.68 499.58

Haleos Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 182.68 0.00 127.34 0.00 499.58
BOM:540679
70GF Score
Haleos Labs Ltd BOM:540679
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹500 Mil mean?
Haleos Labs (BOM:540679) has a Long-Term Debt of ₹500 Mil as of Mar. 2026.
Is Haleos Labs' Long-Term Debt too high?
Haleos Labs' current Long-Term Debt is ₹500 Mil. Overall, Haleos Labs has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Long-Term Debt compare to VRTX and REGN?
Haleos Labs' Long-Term Debt of ₹500 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Haleos Labs's current Long-Term Debt is ₹500 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (BOM:540679) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,130.80, compared to a current price of ₹1,439.10 — trading 27.3% above its estimated fair value. The current Long-Term Debt is ₹500 Mil. Haleos Labs' overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Haleos Labs (BOM:540679), the current Long-Term Debt is ₹500 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleos Labs (BOM:540679) Overvalued in 2026?

Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued. The current stock price of ₹1,439.10 is trading 27.3% above its estimated GF Value™ of ₹1,130.80. GuruFocus considers Haleos Labs to be Modestly Overvalued.

Key valuation signals for BOM:540679:

  • Long-Term Debt: ₹500 Mil
  • GF Value™: ₹1,130.80 vs. price of ₹1,439.10 (27.3% above fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the BOM:540679 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleos Labs Business Description

Other Exchanges HALEOSLABS:India
Address Road Number 71, Plot Number 19 - III, Opposite Bharatiya Vidya Bhavan Public School, Jubilee Hills, Hyderabad, TG, IND, 500096
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
70GF Score

Get the complete analysis for BOM:540679

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,439.10
Price
₹1,130.80
GF Value